🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to determine the safest dose of ZD4054...
Status
Completed
Location
Research Site
Start Date
2003-06
Trial ID
NCT00055471
Treatments Being Tested
The purpose of the study is to assess the effect of food on the pharmacokin...
Status
Completed
Location
Research Site
Start Date
2008-06
Trial ID
NCT00710047
Treatments Being Tested
Peripheral artery disease (PAD) is a major complication of atherosclerosis ...
Status
Completed
Location
University Of Virginia Health System
Start Date
2013-06
Trial ID
NCT01890135
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics of single and m...
Status
Completed
Location
Research Site
Start Date
2009-10
Trial ID
NCT00997945
Treatments Being Tested
This study is being carried out to see if ZD4054 (Zibotentan) is effective ...
Status
Completed
Location
Research Site
Start Date
2004-07
Trial ID
NCT00090363
Treatments Being Tested
This study is designed to compare how ZD4054 (Zibotentan) is taken up, how ...
Status
Completed
Location
Research Site
Start Date
2008-04
Trial ID
NCT00672581
Treatments Being Tested
The purpose of this study is to compare progression-free survival in patien...
Status
Terminated
Location
Research Site
Start Date
2009-06
Trial ID
NCT00929162
Treatments Being Tested
This is a Phase IIb multicentre, randomised, double-blind, parallel-group, ...
Status
Completed
Location
Research Site
Start Date
2024-02-15
Trial ID
NCT06269484
The purpose of the study is to assess efficacy, safety and tolerability of ...
Status
Completed
Location
Research Site
Start Date
2021-04-28
Trial ID
NCT04724837
Treatments Being Tested
The aim of this study is to test the hypothesis that the effects on albumin...
Status
Completed
Location
Anschutz Medical Campus
Start Date
2022-10-06
Trial ID
NCT05570305
Treatments Being Tested